June 26, 2013Journal of Gastroenterology and Hepatology45 citations

Worse outcome of sorafenib therapy associated with ascites and Child‐Pugh score in advanced hepatocellular carcinoma

HKHwi Young KimUniversity of Nebraska Medical Center JPJoong‐Won ParkNational Cancer Center JJJungnam JooNational Institutes of Health

Key Points

Key points are not available for this paper at this time.

Abstract

CP score was more important than CP class in predicting the outcome of sorafenib therapy in patients with advanced HCC. Among the CP score components, presence of ascites was a significant prognostic factor, especially in CPB7 patients.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Kim et al. (2013) studied this question.

synapsesocial.com/papers/69d7ebb63b601d7be3ae3488 https://doi.org/https://doi.org/10.1111/jgh.12310

Demander à l'IA

Bookmark

View Full Paper